A newly identified genetic variant of the mpox virus is driving a significant outbreak in Sierra Leone, revealing a pattern of sustained human-to-human transmission that allowed the virus to circulate undetected for months before the first clinical cases were flagged. The discovery of the G.1 lineage provides a critical window into the genomic epidemiology of the 2025 mpox epidemic in Sierra Leone, shifting the understanding of the crisis from a series of animal-to-human spillovers to a concentrated human epidemic.
Researchers analyzed 340 high-quality viral genomes collected from 14 districts between January and August 2025. The data shows that the vast majority of these cases belong to the G.1 lineage (also known as A.2.2.1), a descendant of the Clade IIb/sh2017 strain that first emerged in southern Nigeria in 2014. Unlike sporadic zoonotic events, the G.1 lineage shows a high prevalence of APOBEC3-characteristic mutations—genetic markers that typically appear when a virus adapts for efficient spread among humans.
This genomic evidence suggests that the virus did not simply jump from animals to humans multiple times. Instead, once the G.1 lineage established itself, it drove a rapid expansion across the country. Approximately 85% of the reconstructed mutations in the G.1 lineage are consistent with this human-driven adaptation, providing a clear genetic fingerprint of an epidemic in motion.
A Hidden Window of Transmission
One of the most striking findings in the genomic data is the gap between when the virus arrived and when health officials noticed it. While the first case was reported on January 10, 2025, Bayesian phylogenetic reconstructions estimate that the G.1 lineage actually became established in Sierra Leone around September 27, 2024.
This implies a “cryptic” circulation period of roughly three months, during which the virus spread silently through the population. This hidden window likely allowed the virus to seed multiple districts before the healthcare system could mount a response. By the time the outbreak was formally recognized in January, active transmission chains were already firmly established in the Western Area Urban (WAU), Port Loko, Bo, and Kenema districts.
The speed of the spread was aggressive. At its peak in early March 2025, the time-varying reproductive number (Rt) reached 4.4, meaning each infected person was passing the virus to more than four others. This contributed to a doubling time of approximately three weeks, leading to a sharp spike in incidence between April and May 2025.
The Epicenter and the Path of Spread
The outbreak’s geography was not random. The Western Area Urban (WAU) district, which includes the densely populated capital of Freetown, served as the primary engine for the epidemic. WAU and the Western Area Rural (WAR) districts accounted for approximately 80% of all cases in the country.
Genomic mapping reveals that WAU acted as a central hub, exporting the virus to other regions in an almost anticlockwise pattern. The virus first spread from the western region into Kenema, then moved to Bo, Port Loko, WAR, and Bonthe. While WAU remained the dominant source of new infections, Kenema later emerged as a secondary hub, further disseminating the virus into Pujehun, Bonthe, and Falaba.
The scale of the epidemic was likely larger than official records suggest. While there were 5,096 confirmed cases, mathematical modeling suggests the actual total may have been closer to 10,400 cases, indicating that a significant portion of the outbreak went unrecorded or unsampled.
Beyond Sierra Leone’s borders, the G.1 lineage has already demonstrated its potential for international spread. Genomic sequencing has identified “viral exports” from Sierra Leone to the United States, Germany, and Guinea, confirming that the local prevalence was high enough to trigger repeated international transmission events.
Breaking the Chain: Interventions and Decline
The trajectory of the outbreak began to shift in the spring of 2025 as public health interventions scaled up. Vaccination campaigns launched on March 26 in the WAU and WAR districts and expanded nationwide by April 30. These efforts, supplemented by ring vaccination of close contacts in June, helped slow the momentum of the G.1 lineage.
However, genomic data suggests that vaccines were only part of the solution. A strong correlation was observed between the decline of transmission chains and the implementation of mandatory isolation. After home-based management proved ineffective in certain settings, the shift to strict isolation was credited as a key driver in reducing the duration of local transmission chains.
| Metric | Estimated Value | Significance |
|---|---|---|
| Peak Reproductive Number (Rt) | 4.4 | High early transmission rate |
| Estimated Emergence Date | Sept 27, 2024 | 3-month undetected circulation |
| Confirmed Cases | 5,096 | PCR-confirmed baseline |
| Inferred Total Cases | ~10,400 | Estimated true burden |
| Primary Epicenter | WAU District | Main hub for national spread |
What This Means for Global Health
The emergence of G.1 highlights a broader trend in the evolution of mpox. The virus is increasingly capable of sustaining itself within human populations without needing frequent “spillovers” from animal reservoirs. This shift increases the risk of localized epidemics becoming global events if surveillance is delayed.
For public health officials, the Sierra Leone experience underscores the importance of genomic surveillance. Without sequencing, the three-month window of cryptic circulation would have remained a mystery, and the specific role of the WAU district as a transmission hub would have been less clear.
Current efforts are focused on maintaining surveillance to ensure that the G.1 lineage—or new descendants—do not re-establish persistent chains of transmission. For the latest official guidance on prevention and symptoms, the World Health Organization and the Centers for Disease Control and Prevention provide updated public health resources.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare provider for diagnosis and treatment of mpox or other infectious diseases.
Health authorities continue to monitor the genomic drift of the G.1 lineage in West Africa, with the next round of regional surveillance data expected to clarify if the virus has established endemic reservoirs in neighboring countries. We invite readers to share their thoughts and experiences in the comments below.
